TTOO - T2 Biosystems GAAP EPS of -$1.32 misses by $0.07 revenue of $2.1M misses by $0.23M
2023-05-23 08:13:48 ET
- T2 Biosystems press release ( NASDAQ: TTOO ): Q1 GAAP EPS of -$1.32 misses by $0.07 .
- Revenue of $2.1M (-71.0% Y/Y) misses by $0.23M .
- Shares +6% PM.
- The company reiterates its FY2023 financial outlook and continues to expect total sepsis and related product revenue of $11.0 million to $13.0 million, representing growth of 31% to 55%, compared to $8.4 million in 2022. Given the focus on product revenue, the company is not providing guidance on research and contribution revenue.
For further details see:
T2 Biosystems GAAP EPS of -$1.32 misses by $0.07, revenue of $2.1M misses by $0.23M